24 reports of this reaction
1.5% of all STANNOUS FLUORIDE reports
#17 most reported adverse reaction
HYPOAESTHESIA ORAL is the #17 most commonly reported adverse reaction for STANNOUS FLUORIDE, manufactured by Haleon US Holdings LLC. There are 24 FDA adverse event reports linking STANNOUS FLUORIDE to HYPOAESTHESIA ORAL. This represents approximately 1.5% of all 1,587 adverse event reports for this drug.
Patients taking STANNOUS FLUORIDE who experience hypoaesthesia oral should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPOAESTHESIA ORAL is a less commonly reported adverse event for STANNOUS FLUORIDE, but still significant enough to appear in the safety profile.
In addition to hypoaesthesia oral, the following adverse reactions have been reported for STANNOUS FLUORIDE:
The following drugs have also been linked to hypoaesthesia oral in FDA adverse event reports:
HYPOAESTHESIA ORAL has been reported as an adverse event in 24 FDA reports for STANNOUS FLUORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPOAESTHESIA ORAL accounts for approximately 1.5% of all adverse event reports for STANNOUS FLUORIDE, making it a notable side effect.
If you experience hypoaesthesia oral while taking STANNOUS FLUORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.